Literature DB >> 24451071

Liquisolid systems and aspects influencing their research and development.

Barbora Vraníková, Jan Gajdziok.   

Abstract

Many modern drugs are poorly water soluble substances, which causes difficulties in the development of solid dosage forms with sufficient bioavailability. Preparation of liquisolid systems (LSS) is a novel technique for improving solubility, dissolution and bioavailability of such drugs. The basic principle of LSS preparation is conversion of the drug in liquid state into a free-flowing, compressible, dry powder through its absorption into suitable excipients - porous carriers (aluminometasilicates, microcrystalline cellulose), subsequently coated with material having high absorption capacity (silicon dioxide commonly known as colloidal silica). LSS exhibit advantages such as lower production costs compared to soft capsules, simple processing and enhanced drug release. The main benefit is higher bioavailability of the liquid drug, caused by a large surface area available for absorption. The article tries to clarify specific aspects connected with the formulation of LSS: properties of excipients (surface area, absorption capacity), variables related to the processing (solubility, liquid load factor) and dosage form evaluation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24451071     DOI: 10.2478/acph-2013-0034

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  8 in total

1.  Evaluation and Comparison of Three Types of Spray Dried Coprocessed Excipient Avicel® for Direct Compression.

Authors:  Pavlína Vodáčková; Barbora Vraníková; Petra Svačinová; Aleš Franc; Jan Elbl; Jan Muselík; Roman Kubalák; Tomaš Solný
Journal:  Biomed Res Int       Date:  2018-04-19       Impact factor: 3.411

2.  Systematic Development of Self-Nanoemulsifying Liquisolid Tablets to Improve the Dissolution and Oral Bioavailability of an Oily Drug, Vitamin K1.

Authors:  Yongtao Tong; Yuli Wang; Meiyan Yang; Jiahui Yang; Lu Chen; Xiaoyang Chu; Chunhong Gao; Qian Jin; Wei Gong; Chunsheng Gao
Journal:  Pharmaceutics       Date:  2018-07-18       Impact factor: 6.321

3.  Formulation and Evaluation of Self-Nanoemulsifying Drug Delivery System Derived Tablet Containing Sertraline.

Authors:  Anroop B Nair; Bhavna Singh; Jigar Shah; Shery Jacob; Bandar Aldhubiab; Nagaraja Sreeharsha; Mohamed A Morsy; Katharigatta N Venugopala; Mahesh Attimarad; Pottathil Shinu
Journal:  Pharmaceutics       Date:  2022-01-31       Impact factor: 6.321

4.  Studies on Preformulation and Formulation of JIN-001 Liquisolid Tablet with Enhanced Solubility.

Authors:  Han-Sol Kim; Chang-Min Kim; An-Na Jo; Joo-Eun Kim
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-28

5.  Novel Extraction Method Using Excipients to Enhance Yield of Genistein and Daidzein in Trifolium pratensis L.

Authors:  Jurga Andreja Kazlauskaite; Liudas Ivanauskas; Jurga Bernatoniene
Journal:  Pharmaceutics       Date:  2021-05-22       Impact factor: 6.321

6.  Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance.

Authors:  Petra Obioma Nnamani; Agatha Adaora Ugwu; Emmanuel Chinedu Ibezim; Franklin Chimaobi Kenechukwu; Paul Achile Akpa; John-Dike Nwabueze Ogbonna; Nicholas Chinedu Obitte; Amelia Ngozi Odo; Maike Windbergs; Claus-Michael Lehr; Anthony Amaechi Attama
Journal:  Int J Nanomedicine       Date:  2016-11-28

Review 7.  Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.

Authors:  Xingwang Zhang; Huijie Xing; Yue Zhao; Zhiguo Ma
Journal:  Pharmaceutics       Date:  2018-06-23       Impact factor: 6.321

8.  Hydrophilic and Functionalized Nanographene Oxide Incorporated Faster Dissolving Megestrol Acetate.

Authors:  Mohammad Saiful Islam; Faradae Renner; Kimberly Foster; Martin S Oderinde; Kevin Stefanski; Somenath Mitra
Journal:  Molecules       Date:  2021-03-31       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.